Fulcrum Therapeutics FULC
NASDAQ FULC
$3.68 +0.00 (+0.00%)
As of: Oct 2, 2026 · 11:24 AM EDT

Fulcrum Therapeutics (FULC) Net Equity Issued and Repurchased (2018 - 2026)

Updated

Fulcrum Therapeutics' Net Equity Issued and Repurchased was $356,000 in Q2 2026, up 18.3% from $301,000 a year earlier.

Analysis

Fulcrum Therapeutics (FULC) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Fulcrum Therapeutics' Net Equity Issued and Repurchased was $4.24 million through Jun 30, 2026, up 316.4% year-over-year; for FY2025, it came in at $4.17 million, up 51.7% from FY2024.

  • Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -42.1% (FY2020 to FY2025).
  • In earlier years, Net Equity Issued and Repurchased was $2.75 million in FY2024 (+253.4%), $777,000 in FY2023 (-77.9%), $3.52 million in FY2022 (-4.1%) and $3.67 million in FY2021 (-94.3%).
  • Quarterly Net Equity Issued and Repurchased has moved between $21,000 (Q1 2026) and $3.8 million (Q4 2025) over five years.
  • Compared with a year earlier, Net Equity Issued and Repurchased was higher in 1 of the last four quarters, with an average decline of 40.7%.
  • The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q1 2024 (growth of 374.4%); the worst was Q3 2022 (a decline of 96.1%).
  • Per Business Quant data, FULC's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $21,000 (Q1 2026), $3.8 million (Q4 2025) and $64,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Fulcrum Therapeutics 282.26 Mn 282.26 Mn - 356,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 356,000.00
Mar 31, 2026 21,000.00
Dec 31, 2025 3.80 Mn
Sep 30, 2025 64,000.00
Jun 30, 2025 301,000.00
Dec 31, 2024 83,000.00
Sep 30, 2024 635,000.00
Jun 30, 2024 377,000.00
Mar 31, 2024 1.65 Mn
Dec 31, 2023 287,000.00
Jun 30, 2023 142,000.00
Mar 31, 2023 348,000.00
Dec 31, 2022 267,000.00
Sep 30, 2022 93,000.00
Jun 30, 2022 2.81 Mn
Mar 31, 2022 348,000.00
Dec 31, 2021 969,000.00
Sep 30, 2021 2.38 Mn
Jun 30, 2021 231,000.00
Mar 31, 2021 93,000.00
API Access

Fulcrum Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=FULC&period=max&api_key=YOUR_API_KEY